News › Clinical Practice, Industry News, Patient Care

Ozempic and Wegovy May Help Curb Alcohol Addiction, Study Suggests

November 15, 2024
injection pens

The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA Psychiatry suggests.

In a study of around 228,000 people in Sweden who had alcohol use disorder, researchers found that people who were taking a GLP-1 drug like semaglutide were less likely to be hospitalized for alcohol-related issues.

Just over 28 million adults in the U.S. have alcohol addiction, according to the National Institute on Alcohol Abuse and Alcoholism.

Only three medicines, however, are approved to treat it.

Read more at NBC News >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • FDA Warning Letter Signals Increased Scrutiny of the Medical Necessity Exception for Compounded GLP-1s
    • Allergan Aesthetics Debuts AA Signature in the United States with SKIN360
    • Candela Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • FDA Approves Additional Warning for Kybella Labeling
    • Federal Bill Would Establish New Ownership and Management Requirements for Medical Practices
Advertisement